Keyphrases
Chemotherapy
69%
5-fluorouracil (5-FU)
54%
Radiation Therapy
43%
Breast Cancer
42%
Colorectal Cancer
35%
Israel
34%
Cisplatin
32%
Cyclophosphamide
29%
Doxorubicin
29%
Tumor
29%
Breast Carcinoma
25%
Methotrexate
24%
Radiotherapy
23%
Complete Response
23%
Adriamycin
21%
Partial Response
21%
Disease-free Survival
20%
Metastatic Melanoma
20%
Adjuvant Chemotherapy
19%
Combination Chemotherapy
19%
Prognostic Factors
19%
Merkel Cell Carcinoma
19%
Capecitabine
19%
Early Breast Cancer
19%
Overall Survival
18%
Medical Center
17%
Docetaxel
16%
Cancer Patients
16%
Consecutive Patients
15%
Gastric Cancer
15%
Locally Advanced Breast Cancer
15%
Advanced Gastric Cancer
15%
Positron Emission Tomography-computed Tomography (PET-CT)
15%
Israeli
15%
Adjuvant Therapy
14%
Pathological Complete Response
14%
Leucovorin
14%
Preoperative Chemoradiation
14%
Ashkenazi
14%
Metastatic Breast Cancer
14%
Median Survival
13%
Liposomes
13%
Disease-free
13%
Adenocarcinoma
13%
In Cancer
13%
Malignant Melanoma
13%
High Dose
13%
Phase II Study
13%
Multivariate Analysis
13%
Patients with Breast Cancer
13%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Breast Cancer
71%
Neoplasm
56%
Diseases
49%
Doxorubicin
46%
Fluorouracil
46%
Malignant Neoplasm
37%
Chemoradiation Therapy
36%
Colorectal Carcinoma
35%
Cisplatin
34%
Abdominal Cancer
33%
Cyclophosphamide
26%
Recurrent Disease
25%
Overall Survival
25%
Breast Carcinoma
23%
Methotrexate
21%
Docetaxel
19%
Capecitabine
19%
Survival Rate
15%
Liposome
15%
Folinic Acid
15%
Remission
14%
Disease Free Survival
14%
Clinical Trial
13%
Melanoma
13%
Primary Tumor
13%
Esophagus Cancer
13%
Prospective Study
13%
Dacarbazine
12%
Merkel Cell Carcinoma
11%
Mitomycin
11%
Rectum Cancer
11%
Polyethylene Terephthalate
11%
Pharmacokinetics
11%
Side Effect
10%
Vinblastine
10%
Clinical Study
9%
Retrospective Study
9%
Bone Metastasis
9%
Ovary Cancer
9%
Diarrhea
9%
Leukopenia
9%
Paclitaxel
8%
Colon Carcinoma
8%
Bone Marrow Suppression
8%
Progression Free Survival
8%
Trastuzumab
8%
Taxane
7%
Cetuximab
7%
Aminoglutethimide
7%
Medicine and Dentistry
Breast Cancer
78%
Neoplasm
65%
Radiation Therapy
60%
Diseases
49%
Chemoradiotherapy
32%
Metastatic Carcinoma
29%
Doxorubicin
27%
Recurrent Disease
26%
Overall Survival
26%
Colorectal Carcinoma
25%
Cancer
24%
Fluorouracil
23%
Cisplatin
22%
Prognostic Factor
22%
Cyclophosphamide
20%
Breast Carcinoma
20%
Melanoma
20%
Rectum Cancer
16%
Survival Rate
16%
Disease Free Survival
16%
Combination Chemotherapy
15%
Locally Advanced Breast Cancer
15%
Methotrexate
15%
Merkel Cell Carcinoma
15%
Positron Emission Tomography-Computed Tomography
15%
Esophageal Cancer
15%
Adjuvant Therapy
14%
Squamous Cell Carcinoma
13%
Prospective Study
13%
Retrospective Study
13%
Vinblastine
13%
Adenocarcinoma
12%
Primary Tumor
12%
Adjuvant Chemotherapy
12%
Metastatic Breast Cancer
11%
Dacarbazine
11%
Airway Obstruction
11%
Capecitabine
11%
Kaposi Sarcoma
11%
Laryngeal Cancer
11%
Multivariate Analysis
11%
Brachytherapy
11%
Ovarian Cancer
11%
Oncotype DX
10%
Drug Megadose
10%
Abdominal Cancer
9%
Clinical Study
9%
Pelvis
9%
Malignant Neoplasm
8%
Colon Carcinoma
8%